▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Keith Speights

TMFFishBiz

Keith Speights is a contributing Motley Fool Healthcare Analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, and marijuana. Prior to The Motley Fool, Speights was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.

Recent Articles by Keith Speights

Cannabis leaf in shopping cart

Sep 18, 2020 by Keith Speights

Better Marijuana Stock: Green Thumb Industries vs. GrowGeneration

Which stock wins in a matchup between a leading multistate cannabis operator and the top hydroponics retail chain?

3 coronavirus vaccine bottles with syringe

Sep 18, 2020 by Keith Speights

3 Coronavirus Vaccines in Phase 3 Clinical Studies: How They Stack Up Against Each Other

There's also one other candidate that's hot on their heels.

Arrows hitting target with dollar sign

Sep 18, 2020 by Keith Speights

3 Cheap Stocks You Can Buy and Hold for Decades

Most stocks are anything but cheap right now. These are three great exceptions.

Scientists with tablet displaying coronavirus

Sep 17, 2020 by Keith Speights

Why Vaxart Stock Is Vaulting Higher Today

Yesterday's momentum is accelerating.

Vaccine with question mark written on face mask

Sep 17, 2020 by Keith Speights

3 Reasons Why You Probably Won't Receive a Coronavirus Vaccine Shot by the End of 2020

You'll have a much better shot at getting a shot next year.

Bubble with dollar sign

Sep 17, 2020 by Keith Speights

Stock Market Crash 2.0: Here Are 3 Stocks You'll Absolutely, Positively Want to Buy

These stocks are great candidates to buy on the dip -- especially if that dip is a big one.

Vaccine bottle and syringe with blue background

Sep 17, 2020 by Keith Speights

Here's the Company That Bill Gates Thinks Is the Clear Coronavirus Vaccine Leader

The billionaire philanthropist thinks one company could have a coronavirus vaccine ready by November.

Sticky note with coronavirus over a dollar sign

Sep 16, 2020 by Keith Speights

Why Inovio Stock Is Soaring Again Today

Investors remain enthusiastic about comments made earlier this week by Inovio's CEO.

Businessman with lines going up from his hand

Sep 16, 2020 by Keith Speights

3 Great Stocks With Better Growth Prospects Than Tesla to Buy

They're all innovative disruptors, but these three stocks could outperform Tesla over the next decade.

Dollar boats

Sep 16, 2020 by Keith Speights

3 Steady Stocks to Buy in a Highly Volatile Market

These stocks have what you want during turbulent times: solid business models, stable cash flows, and reliable dividends.

2020 through 2025 painted on road

Sep 16, 2020 by Keith Speights

Where Will Gilead Sciences Be in 5 Years?

Some things are easy to predict for the big biotech. Others aren't.

Drawing of brain with brain wave lines

Sep 15, 2020 by Keith Speights

Why Marinus Pharmaceuticals Stock Skyrocketed 80% Higher Today

Investors are thrilled with the results from a late-stage clinical study of the company's only pipeline drug candidate.

Woman drawing big yellow fish about to eat small yellow fish

Sep 15, 2020 by Keith Speights

Should You Buy Gilead Now That It's Acquiring Immunomedics?

It's going to be a while before we know if Gilead's $21 billion deal will pay off.

Businessman with arrows pointing up and viruses

Sep 15, 2020 by Keith Speights

These 3 Coronavirus Stocks Could More Than Double by the End of 2020

Each of these biotech stocks has more than tripled year to date and could still have plenty of room to run.

Syringe, globe, currency symbols

Sep 15, 2020 by Keith Speights

How Novavax Is Keeping Up With the Big Players in the Coronavirus Vaccine Race

This small biotech could be the biggest winner of all if its COVID-19 vaccine performs well in late-stage testing.

Doctor reviewing brain MRI scans

Sep 14, 2020 by Keith Speights

Why Ziopharm Oncology Shares Zoomed Higher Today

One of the biotech's pipeline candidates won a key FDA designation.

Scientist looking through microscope

Sep 14, 2020 by Keith Speights

Why VBI Vaccines Stock Jumped Today

The biotech will present additional data for one of its pipeline candidates later this week.

Green light arrow

Sep 14, 2020 by Keith Speights

Why Vaxart Stock Is Crushing It Today

The FDA gave a green light for the biotech to begin phase 1 testing of its coronavirus vaccine candidate.

Doctor holding COVID-19 vaccine with thumb up

Sep 13, 2020 by Keith Speights

The Surefire Vaccine Winner Following AstraZeneca's COVID-19 Trial Pause

Hint: It's not Moderna.

Cannabis plants with hydroponics

Sep 13, 2020 by Keith Speights

Could GrowGeneration Be a Millionaire-Maker Stock?

Maybe. Here's how it could happen.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services